Reduced-intensity Conditioning Allogeneic Hematopoietic Cell Transplantation
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload.
- Status
- COMPLETED
- Phase
- PHASE4
Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal Disease
- Status
- COMPLETED
- Phase
- PHASE2
Study of REVLIMID (Lenalidomide) Versus Placebo in Patients With Low Risk Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers
- Status
- UNKNOWN
- Phase
- PHASE2
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE3
AHN-12 Biodistribution in Advanced Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE4
Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE3
Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE3
Revlimid in Transfusion Dependent Patients
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias
- Status
- COMPLETED
- Phase
- PHASE1
Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDS
- Status
- COMPLETED
- Phase
- PHASE1
Bioequivalence Study of Azacitidine for Injection in Myelodysplastic Syndrome (MDS) Patients
- Status
- COMPLETED
- Phase
- PHASE1
Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients
- Status
- COMPLETED
- Phase
- N/A
Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers
- Status
- TERMINATED
- Phase
- PHASE2
Use of Decitabine in Myelodysplastic Syndrome (MDS) Following Azacitidine (AZA) Failure
- Status
- UNKNOWN
- Phase
- PHASE2